Mercurial listed investment group Sino Securities is promoting Chinese medicine on the Internet. Sino managing director Richard Li has teamed up with Chinese medical practitioner Tzi Chiang Lin to form a new company, Pharmasafe, that will market Professor Tzi's Chinese remedies online.

Pharmasafe will be 60 per cent owned by Professor Tzi and 40per cent by Sino Securities. Professor Tzi will provide intellectual property, built up over 30 years, to the joint venture while Sino will provide investment banking services. Sino subsidiary, the Internet group GoConnect, will provide the Internet presence for Pharmasafe to operate.

Mr Li said GoConnect's GoTrek function would provide online video information about hepatitis and the Pharmasafe remedy.

He said the first product to be sold by Pharmasafe would be a hepatitis B treatment developed by Professor Tzi from traditional Chinese remedies.

The treatment, taken in pill form, has a track record of removing symptoms in about 75per cent of cases, restoring liver function and ensuring patients can lead healthy, normal lives without the danger of transmitting the disease to others. In some 10per cent of cases, the disease is totally cured.

Professor Tzi said he hoped that the Internet would allow him to reach large numbers of people across the world and that he planned to find other remedies to build his online presence.

Mr Li said the venture was in the Australian drug-approval process.

He said the Pharmasafe site was likely to be operational within nine to 12 months.